in order to include the actual-trading price into the drug pricing method.
The insurance drug pricing system of Japan is tightly woven to marketing structure of the pharmaceutical industry.
(1)-2 The changes of the drug pricing system
In 1958 the minister of labor welfare has established the current drug pricing system which determines the purchase price and is updated ev
2. Value Enhancement
For value enhancement, in the view point of regional development, the result was not that successful. To enhance the created value, the knowledge and technology should be transferred to the region consistently, but most of transnational pharmaceutical companies inKoreaincluding Pfizer have a defensive stand for that.
All pharmaceutical corporations inKorea are the m
1. History and introduction of Dong A pharmaceutical
Dong-A Pharmaceutical is the leading pharmaceutical company inKorea. Dong-A stands at the forefront of Korea's pharmaceutical industry; motivated by its respect for life and health to continuously innovate and develop products that enhance people's quality of life. We are working hard to grow internationally and become one of the world's most
in 1973 based on mottoes –“Human Respect” & “Creation of Value”, Hanmi has endless exerted all its power for precious human life. For the purpose of the progress of pharmaceutical industry and the supply of highly qualified medicines with the most advanced facilities according to KGMP. These efforts has made Hanmi one of the leading and promising pharmaceutical companies inKorea. S
REBATE?
Literally
Paying back a portion of the payment or interest to the payee
In the field of medicine
Pharmaceutical company pays back to the hospital
through negative market
Cause of Rebate inKorea
K-1. Special characteristics of Medical industry
Patients have no option in choice of drugs
Doctors have the incentive to use their
professionalism to maximize their p